Alvotech (ALVO)
13.49
-0.01
(-0.07%)
USD |
NASDAQ |
May 17, 16:00
13.49
0.00 (0.00%)
After-Hours: 20:00
Alvotech Debt to Equity Ratio: -1.030 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.030 |
| September 30, 2023 | -1.380 |
| June 30, 2023 | -1.690 |
| March 31, 2023 | -1.210 |
| December 31, 2022 | -1.355 |
| Date | Value |
|---|---|
| September 30, 2022 | -1.871 |
| June 30, 2022 | -1.887 |
| March 31, 2022 | |
| December 31, 2021 | -2.956 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.956
Minimum
Dec 2021
-1.030
Maximum
Dec 2023
-1.672
Average
-1.535
Median
Debt to Equity Ratio Benchmarks
| AbbVie Inc | 9.242 |
| Teva Pharmaceutical Industries Ltd | 2.699 |
| Moolec Science SA | 1.174 |
| Procaps Group SA | 7.361 |
| NeuroMetrix Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 950.09M |
| Total Liabilities (Quarterly) | 1.883B |
| Shareholders Equity (Quarterly) | -932.49M |
| Current Ratio | 0.7467 |
| Net Debt Paydown Yield | -2.88% |